| m6A RNA methylation and beyond–The epigenetic machinery and potential treatment options S Garbo, C Zwergel, C Battistelli Drug discovery today 26 (11), 2559-2574, 2021 | 63 | 2021 |
| Design and functional validation of a mutant variant of the LncRNA HOTAIR to counteract snail function in epithelial-to-mesenchymal transition C Battistelli, S Garbo, V Riccioni, C Montaldo, L Santangelo, A Vandelli, ... Cancer research 81 (1), 103-113, 2021 | 46 | 2021 |
| The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter B Fazi, S Garbo, N Toschi, A Mangiola, M Lombari, D Sicari, C Battistelli, ... Oncotarget 9 (21), 15512, 2018 | 46 | 2018 |
| Next RNA therapeutics: the mine of non-coding S Garbo, R Maione, M Tripodi, C Battistelli International journal of molecular sciences 23 (13), 7471, 2022 | 43 | 2022 |
| Selenium-containing agents acting on cancer—a new hope? S Garbo, S Di Giacomo, D Łażewska, E Honkisz-Orzechowska, A Di Sotto, ... Pharmaceutics 15 (1), 104, 2022 | 24 | 2022 |
| Seleno-vs. thioether triazine derivatives in search for new anticancer agents overcoming multidrug resistance in lymphoma W Ali, S Garbo, A Kincses, M Nové, G Spengler, E Di Bello, ... European Journal of Medicinal Chemistry 243, 114761, 2022 | 12 | 2022 |
| Restoration of WT1/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells G Bontempi, M Terri, S Garbo, C Montaldo, D Mariotti, V Bordoni, ... Cell Death & Disease 13 (11), 965, 2022 | 11 | 2022 |
| MyoD-induced trans-differentiation: a paradigm for dissecting the molecular mechanisms of cell commitment, differentiation and reprogramming C Battistelli, S Garbo, R Maione Cells 11 (21), 3435, 2022 | 10 | 2022 |
| Novel 1, 4-dihydropyridines as specific binders and activators of SIRT3 impair cell viability and clonogenicity and downregulate hypoxia-induced targets in cancer cells C Zwergel, M Aventaggiato, S Garbo, E Di Bello, B Fassari, B Noce, ... Journal of Medicinal Chemistry 66 (14), 9622-9641, 2023 | 7 | 2023 |
| SYNCRIP modulates the epithelial-mesenchymal transition in hepatocytes and HCC cells V Riccioni, F Trionfetti, C Montaldo, S Garbo, F Marocco, C Battistelli, ... International Journal of Molecular Sciences 23 (2), 913, 2022 | 7 | 2022 |
| lncRNA HOTAIR functions and therapeutic perspectives S Garbo, M Tripodi, C Battistelli Oncoscience 9, 49, 2022 | 7 | 2022 |
| First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease P Pyka, W Haberek, M Więcek, E Szymanska, W Ali, A Cios, ... Journal of Medicinal Chemistry 67 (2), 1580-1610, 2024 | 6 | 2024 |
| A novel RNA-based approach to counteract EMT S Garbo, M Tripodi, C Battistelli Oncoscience 8, 53-54, 2021 | 3 | 2021 |
| m6A modification inhibits miRNAs’ intracellular function, favoring their extracellular export for intercellular communication S Garbo, D D’Andrea, A Colantoni, F Fiorentino, A Mai, A Ramos, ... Cell Reports 43 (6), 2024 | 1 | 2024 |
| Selenium-containing compounds: a new hope for innovative treatments in Alzheimer’s disease and Parkinson’s disease P Pyka, S Garbo, R Fioravanti, C Jacob, M Hittinger, J Handzlik, ... Drug Discovery Today, 104062, 2024 | | 2024 |
| Selenium-containing compounds: a new hope for innovative treatments in Alzheimer’s disease and Parkinson’s P Pyka, S Garbo, R Fioravanti, C Jacob, M Hittinger, J Handzlik, ... | | |
